This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2020 Dec;2(12):e729-e730.

doi: 10.1016/S2665-9913(20)30353-2. Epub 2020 Sep 28.

The opening salvo of anti-complement therapy against COVID-19

Courtney M Campbell¹

Affiliations

PMID: 33015642
PMCID: PMC7521911
DOI: 10.1016/S2665-9913(20)30353-2

The opening salvo of anti-complement therapy against COVID-19

Courtney M Campbell. Lancet Rheumatol. 2020 Dec.

. 2020 Dec;2(12):e729-e730.

doi: 10.1016/S2665-9913(20)30353-2. Epub 2020 Sep 28.

Author

Courtney M Campbell¹

Affiliation

¹ Division of Cardiovascular Medicine, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.

PMID: 33015642
PMCID: PMC7521911
DOI: 10.1016/S2665-9913(20)30353-2

No abstract available

PubMed Disclaimer

Similar articles

Opening guns: strategy behind Carter salvo against the AMA.
Ryan AJ. Ryan AJ. Postgrad Med. 1978 Jun;63(6):16. doi: 10.1080/00325481.1978.11714848. Postgrad Med. 1978. PMID: 652674 No abstract available.
Opening Salvo.
Katz P, Yelin E. Katz P, et al. ACR Open Rheumatol. 2019 Mar 15;1(1):3. doi: 10.1002/acr2.1004. eCollection 2019 Mar. ACR Open Rheumatol. 2019. PMID: 31777775 Free PMC article. No abstract available.
On Brown's opening salvo.
Stevens S. Stevens S. Health Serv J. 2007 Jun 7;117(6059):19. Health Serv J. 2007. PMID: 17621886 No abstract available.
Qui tam on the lam: Fifth Circuit fires the first salvo--will the Supreme Court be next?
Mayo TW. Mayo TW. Health Care Law Mon. 1999 Dec:3-8. Health Care Law Mon. 1999. PMID: 10788161 Review. No abstract available.
Transplantation of Mesenchymal Stem Cells: A Potential Adjuvant Therapy for COVID-19.
Zhu Y, Geng S, Li Q, Jiang H. Zhu Y, et al. Front Bioeng Biotechnol. 2020 Nov 5;8:557652. doi: 10.3389/fbioe.2020.557652. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 33224928 Free PMC article. Review.

See all similar articles

Cited by

The complement system in pediatric acute kidney injury.
Stenson EK, Kendrick J, Dixon B, Thurman JM. Stenson EK, et al. Pediatr Nephrol. 2023 May;38(5):1411-1425. doi: 10.1007/s00467-022-05755-3. Epub 2022 Oct 6. Pediatr Nephrol. 2023. PMID: 36203104 Free PMC article. Review.
Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses.
Jordan SC. Jordan SC. Clin Exp Immunol. 2021 Jun;204(3):310-320. doi: 10.1111/cei.13582. Epub 2021 Mar 4. Clin Exp Immunol. 2021. PMID: 33534923 Free PMC article. Review.
COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes.
MacDonald L, Alivernini S, Tolusso B, Elmesmari A, Somma D, Perniola S, Paglionico A, Petricca L, Bosello SL, Carfì A, Sali M, Stigliano E, Cingolani A, Murri R, Arena V, Fantoni M, Antonelli M, Landi F, Franceschi F, Sanguinetti M, McInnes IB, McSharry C, Gasbarrini A, Otto TD, Kurowska-Stolarska M, Gremese E. MacDonald L, et al. JCI Insight. 2021 Jun 18;6(13):e147413. doi: 10.1172/jci.insight.147413. JCI Insight. 2021. PMID: 34143756 Free PMC article.
Exploratory mass cytometry analysis reveals immunophenotypes of cancer treatment-related pneumonitis.
Yanagihara T, Hata K, Matsubara K, Kunimura K, Suzuki K, Tsubouchi K, Ikegame S, Baba Y, Fukui Y, Okamoto I. Yanagihara T, et al. Elife. 2024 Apr 12;12:RP87288. doi: 10.7554/eLife.87288. Elife. 2024. PMID: 38607373 Free PMC article.
C1 Esterase Inhibition: Targeting Multiple Systems in COVID-19.
Adesanya TMA, Campbell CM, Cheng L, Ogbogu PU, Kahwash R. Adesanya TMA, et al. J Clin Immunol. 2021 May;41(4):729-732. doi: 10.1007/s10875-021-00972-1. Epub 2021 Jan 21. J Clin Immunol. 2021. PMID: 33474624 Free PMC article. Review. No abstract available.

References

1. Carvelli J, Demaria O, Vély F. Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis. Nature. 2020 doi: 10.1038/s41586-020-2600-6. published online July 29. - DOI - PMC - PubMed
1. Shen B, Yi X, Sun Y. Proteomic and metabolomic characterization of COVID-19 patient sera. Cell. 2020;182:59–72.e15. - PMC - PubMed
1. Cugno M, Meroni PL, Gualtierotti R. Complement activation in patients with COVID-19: a novel therapeutic target. J Allergy Clin Immunol. 2020;146:215–217. - PMC - PubMed
1. Magro C, Mulvey JJ, Berlin D. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020;220:1–13. - PMC - PubMed
1. Mastaglio S, Ruggeri A, Risitano AM. The first case of COVID-19 treated with the complement C3 inhibitor AMY-101. Clin Immunol. 2020;215 - PMC - PubMed

LinkOut - more resources

Full Text Sources